- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on EGFR Overexpression
Total 341 results
-
Sun Yat-sen UniversityRecruitingBrain Metastases | Radiotherapy | EGFR Activating MutationChina
-
Fujian Cancer HospitalNot yet recruitingNon-small Cell Lung Cancer Confirmed by Histopathology or Cytology | The TNM (8th) Phase is IV | With EGFR Mutations | Meningeal Progression Occurred After Previous Platinum-containing Two-drug Chemotherapy and Third-generation EGFR-TKI Treatment | Male or Female | The Age of 18 Years Old or... and other conditions
-
Chang Gung Memorial HospitalCompletedAdult Hepatocellular Carcinoma | Recurrent Hepatocellular Carcinoma | Adverse Reaction to Drug | Vascular Endothelial Growth Factor OverexpressionTaiwan
-
TYK Medicines, IncRecruitingNSCLC | EGFR Activating MutationChina
-
Hunan Province Tumor HospitalRecruitingCarcinoma, Non-Small Cell Lung | EGFR Gene MutationChina
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Daping Hospital and the Research Institute of Surgery...CompletedNSCLC | Advanced Cancer | EGFR Gene Amplification | Stage IV NSCLC | Stage IIIB NSCLCChina
-
Sichuan Cancer Hospital and Research InstituteNot yet recruitingNon-squamous Non-small Cell Lung Cancer | EGFR Gene MutationChina
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.RecruitingEGFR Positive Non-small Cell Lung CancerChina
-
Centre Francois BaclesseHoffmann-La Roche; Groupe Français de Pneumo-CancérologieTerminatedNSCLC Patients With EGFR Activating MutationFrance
-
The Fourth Affiliated Hospital of Zhejiang University...CompletedNSCLC | EGFR Gene Mutation | Non-small-lung-cell CancerChina
-
Shanghai Chest HospitalCompletedLung Adenocarcinoma | EGFR Activating Mutation
-
The University of Hong KongUnknownNSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIBHong Kong
-
Betta Pharmaceuticals Co., Ltd.UnknownAdenocarcinoma | EGFR Positive Non-small Cell Lung CancerChina
-
Betta Pharmaceuticals Co., Ltd.UnknownAdenocarcinoma | EGFR Positive Non-small Cell Lung CancerChina
-
Amsterdam UMC, location VUmcUnknownNSCLC | EGFR-mutation | HER2-expressionNetherlands
-
Indiana University School of MedicineAstraZenecaTerminatedRefractory Germ Cell Tumors Expressing EGRFUnited States
-
Fudan UniversityNot yet recruitingNon-muscle Invasive Bladder Cancer | HER-2 Protein Overexpression
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | CD20 Positive | Refractory Mantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | CCND1 Protein Overexpression | CD5 Positive | FCER2 Negative | Pleomorphic Variant Mantle Cell Lymphoma | t(11;14)(q13;q32)United States
-
Radiotherapy Oncology Centre "Santa Maria" HospitalPaola Anselmo,MD; Michelina Casale,PhD; Fabio Trippa,MDRecruitingNSCLC | Non Small Cell Lung Cancer | EGF-R Positive Non-Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | NSCLC Stage IV | Oligometastatic Disease | Non-Small Cell Squamous Lung Cancer | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor | Non-Small Cell Adenocarcinoma and other conditionsItaly
-
Suzhou Genhouse Bio Co., Ltd.RecruitingNon-Small Cell Lung Cancer With EGFR MutationChina
-
National Taiwan University HospitalCompletedTumor Progression | EGFR Exon 19 MutationTaiwan
-
Second Affiliated Hospital of Nanchang UniversityNanchang UniversityUnknownNon-small Cell Lung Cancer | EGFR Gene MutationChina
-
Qingdao Central HospitalCompletedEGFR-TKI Resistant MutationChina
-
First People's Hospital of HangzhouUnknownLung Adenocarcinoma | EGFR Positive Non-small Cell Lung Cancer
-
Tianjin Medical University Second HospitalRecruitingHer2 Overexpressing High-Risk Non-Muscle Invasive Bladder Urothelial CarcinomaChina
-
Fujian Cancer HospitalNot yet recruitingEGFR Positive Non-small Cell Lung CancerChina
-
Scorpion Therapeutics, Inc.RecruitingNon-Small Cell Lung Cancer | NSCLC | EGFR/HER2 Exon 20 Insertion MutationUnited States, Taiwan
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruitingEGFR Gene Mutation | Lung Adenocarcinoma Stage III | Lung Adenocarcinoma Stage IVChina
-
Peking Union Medical CollegeRecruitingNon-small Cell Lung Cancer | EGFR T790M | Osimertinib | ddPCRChina
-
Bursa Yüksek İhtisas Education and Research HospitalRecruitingPneumonia, Viral | COVID-19 Pneumonia | EGFR AmplificationTurkey
-
Shanghai JMT-Bio Inc.Active, not recruitingLocal Advanced or Metastatic NSCLC | Harboring EGFR Common MutationChina
-
Sichuan UniversityAstraZenecaTerminatedNon-small Cell Lung Cancer Metastatic | EGFR Activating MutationChina
-
Li Zhang, MDNot yet recruiting
-
Korea University Guro HospitalChong Kun Dang Pharmaceutical Corp.Active, not recruitingEGFR Positive Non-small Cell Lung CancerKorea, Republic of
-
Sichuan Provincial People's HospitalTerminatedStage IV EGFR Mutated Non-Small Cell Lung CancerChina
-
Massachusetts General HospitalBoehringer Ingelheim; University of TexasCompletedNon-small Cell Lung Cancer | EGFR MutationsUnited States
-
Peking University Cancer Hospital & InstituteBetta Pharmaceuticals Co., Ltd.UnknownEGFR Positive Non-Small Cell Lung Cancer,AdenocarcinomaChina
-
Sichuan Provincial People's HospitalUnknownStage IV EGFR Mutated NSCL With Brain MetastasesChina
-
Vincerx Pharma, Inc.TerminatedChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Relapsed Non Hodgkin Lymphoma | Richter Syndrome | MYC Amplification | MYC Overexpression | MYC TranslocationUnited States, Poland
-
The Netherlands Cancer InstituteDaiichi Sankyo, Inc.Not yet recruitingEGFR Gene Mutation | Non-Small Cell Lung Carcinoma | Advanced Non-Small Cell Squamous Lung Cancer
-
J Ints BioRecruitingEGFR Mutant Advanced Non-small Cell Lung CancerKorea, Republic of, United States, Thailand
-
Daiichi SankyoAvailableEpidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung CancerUnited States
-
Yuankai ShiUnknownAdvanced EGFR-TKI-resistant Non-Small Cell Lung Cancer
-
Zhejiang Cancer HospitalUnknownNon-small Cell Lung Cancer | Aquired Resistance | EGFR TKIsChina
-
Samsung Medical CenterAstraZenecaUnknownEGFR Mutation Positive Non-small Cell Lung CancerKorea, Republic of
-
Groupe Français de Pneumo-CancérologieRecruitingMechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion (RESAMEX)Non-small Cell Lung Cancer | EGFR Exon 20 Insertion MutationFrance
-
Daping Hospital and the Research Institute of Surgery...Not yet recruitingNon Small Cell Lung Cancer | EGFR Gene Mutation
-
PfizerCompletedNon-small Cell Lung Cancer With EGFR-Activating MutationsItaly, Poland, China, Hong Kong, Spain, Korea, Republic of, Japan
-
AstraZenecaTerminated